Compare ZVRA & NATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZVRA | NATR |
|---|---|---|
| Founded | 2006 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.9M | 470.3M |
| IPO Year | 2015 | 1995 |
| Metric | ZVRA | NATR |
|---|---|---|
| Price | $9.10 | $25.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $21.71 | $21.33 |
| AVG Volume (30 Days) | ★ 553.2K | 98.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.27 | N/A |
| EPS | ★ 1.16 | 0.83 |
| Revenue | $23,612,000.00 | ★ $454,364,000.00 |
| Revenue This Year | $333.64 | $7.30 |
| Revenue Next Year | $44.19 | $3.44 |
| P/E Ratio | ★ $7.73 | $30.24 |
| Revenue Growth | N/A | ★ 2.03 |
| 52 Week Low | $6.19 | $11.01 |
| 52 Week High | $13.16 | $28.14 |
| Indicator | ZVRA | NATR |
|---|---|---|
| Relative Strength Index (RSI) | 55.64 | 43.07 |
| Support Level | $8.61 | $13.69 |
| Resistance Level | $9.10 | $26.96 |
| Average True Range (ATR) | 0.36 | 1.01 |
| MACD | 0.02 | -0.37 |
| Stochastic Oscillator | 79.27 | 37.64 |
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.